A Novel Approach to Evaluate Amorphous-to-Crystalline Transformation of Active Pharmaceutical Ingredients in Solid Dispersion Using Time-Domain NMR
A Novel Approach to Evaluate Amorphous-to-Crystalline Transformation of Active Pharmaceutical Ingredients in Solid Dispersion Using Time-Domain NMR
复制标题
DOI:
10.1248/cpb.c18-00887
复制
发表时间:
2019-03-01
影响因子:
1.7
通讯作者:
Onuki, Yoshinori
中科院分区:
文献类型:
--
作者:
Okada, Kotaro;Hirai, Daijiro;Onuki, Yoshinori
The aim of this study was to demonstrate the usefulness of the time-domain NMR (TD-NMR) method to characterize the crystalline state of active pharmaceutical ingredients (APIs) containing a solid dispersion. In this study, indomethacin (IMC) was used as a model for poorly water-soluble API. Solid dispersions of IMC were prepared with polyvinylpyrrolidone (PVP) at different weight ratios. First, we measured the T-1 relaxation behavior of solid dispersions. From the result, the T-1 relaxation time (T-1) changed according to the API content; the T-1 tended to increase with increasing API content because the T-1 value of amorphous IMC was longer than that of PVP. Next, we tried to monitor the amorphous-to-crystalline transformation of IMC in the solid dispersion during the thermal stress test. In the case of solid dispersion containing 90% IMC, a clear prolongation of the T-1 could be observed during the thermal stress test. From the powder X-ray diffraction patterns, the change in T-1 relaxation behavior must be caused by the IMC transformation from amorphous to crystalline. From these findings, we were successful in monitoring the IMC amorphous-to crystalline transformation by the changes in T-1 relaxation behavior. Our findings led us to conclude that TD-NMR is a novel approach for the evaluation of crystalline state of APIs in solid dispersions.